Frontiers | A Snapshot of the Global Race for Vaccines Targeting SARS-CoV-2 and the COVID-19 Pandemic
Johnson & Johnson (Janssen Pharmaceutical Cos.) - Single-Shot COVID-19 Vaccine (formerly JNJ-78436735, Ad26.COV2.S)
Johnson & Johnson Announces European Commission Approval for Janssen's Preventive Ebola Vaccine | Johnson & Johnson
COVID-19 Vaccine Janssen, INN-Ad26.COV2-S, recombinant
Current advances in the development of SARS-CoV-2 vaccines
J&J Seeks EUA for COVID-19 Vaccine
Johnson & Johnson Announces Single-Shot Janssen COVID-19 Vaccine Candidate Met Primary Endpoints in Interim Analysis of its Phase 3 ENSEMBLE Trial
What Providers Need To Know About Janssen COVID-19 Vaccine (Johnson & Johnson)
J&J plans to test its COVID-19 vaccine in ages 12-18 soon | Reuters
J&J's single-shot Covid-19 vaccine: the journey to approval
J&J working with Beth Israel to accelerate COVID-19 vaccine developmen
What Providers Need To Know About Janssen COVID-19 Vaccine (Johnson & Johnson)
Maintaining Safety with SARS-CoV-2 Vaccines | NEJM
Developing COVID-19 Vaccines in Record Time NAIIS – 5/12/2020 1
University of Chicago Medicine begins recruiting participants for phase 3 COVID-19 investigational vaccine clinical trial - UChicago Medicine
SARS-CoV-2 Vaccine Development: An Overview and Perspectives | ACS Pharmacology & Translational Science
Frontiers | A Snapshot of the Global Race for Vaccines Targeting SARS-CoV-2 and the COVID-19 Pandemic
AMENDMENT OF SOLICITATIONAVIODIFICATION OF CONTRACT I 89
Vaccines | Free Full-Text | COVID-19 Vaccines (Revisited) and Oral-Mucosal Vector System as a Potential Vaccine Platform
P00081 Modification to MCDC OTA No. W150KN-16-9-1002 BETWEEN JANSSEN PHARMACEUTICALS, INC. 1125 TRENTON-HARBOURTON ROAD TITUSVIL
J&J's Janssen Speeds Up Planned Launch of COVID-19 Vaccine Trial
